(March 31, 2024 at 9:51 pm)brewer Wrote: Artificial intelligence (AI) has identified two plant-based bioactive compounds with potential as glucagon-like-peptide-1 receptor (GLP-1R) agonists for weight loss as possible alternatives to pharmaceutical weight-loss drugs, but with potentially fewer side effects and oral administration.
https://www.medscape.com/viewcollection/37480
Next, it'll be curing cancer.

"What a little moonlight can do." ~ Billie Holiday